Skip to content

Somryst

by Pear Therapeutics, Inc.

510(k) K191716

Somryst is a medical device (FDA Class II; FDA product code QVO, Computerized Behavioral Therapy Device For Insomnia) made by Pear Therapeutics, Inc., cleared under FDA 510(k) K191716 on 23 Mar 2020, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK191716 Date23 Mar 2020ClearedStatusActive

Official records

From the FDA record

Received by the FDA
26 Jun 2019
FDA decision
23 Mar 2020 (Substantially Equivalent)
FDA review time
271 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K191716 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QVO
Device class
Class II
Regulation
21 CFR Part 882.5801
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Devices cleared under K191716

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K191716
UDI-DISize and differences
Somryst
Nox Medical Ehf
651010 / SOMRYST15694311112112 —On the market
Somryst™ 1
Pear Therapeutics, Inc.
110851580008255 —On the market

Other devices from Pear Therapeutics, Inc.

See all devices from Pear Therapeutics, Inc. →